Trinity Biotech (TRIB) Goodwill & Intangibles (2009 - 2025)

Trinity Biotech (TRIB) has reported Goodwill & Intangibles for 17 consecutive years, with $57.0 million the latest figure, recorded in Q4 2025.

• Quarterly Goodwill & Intangibles rose 10.99% year-over-year to $57.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $57.0 million (up 10.99% YoY) and the FY2025 annual result came in at $57.0 million, up 10.99% from the prior year.
• Goodwill & Intangibles grew to $57.0 million in Q4 2025 per TRIB's latest filing, from $55.9 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for TRIB reached as high as $57.0 million in Q4 2025 and fell as low as $15.8 million in Q2 2023.
• A 5-year average of $36.0 million and a median of $36.6 million in 2021 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2023 — Goodwill & Intangibles sank 59.33% — and 2024, when it surged 215.57%.
• Year by year, Goodwill & Intangibles stood at $36.0 million in 2021, then declined by 1.98% to $35.3 million in 2022, then sank by 53.87% to $16.3 million in 2023, then jumped by 215.57% to $51.3 million in 2024, then rose by 10.99% to $57.0 million in 2025.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $57.0 million, $55.9 million, and $51.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.